These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38104236)

  • 21. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
    Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
    Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents.
    Korinek M; Sedlacek M; Cais O; Dittert I; Vyklicky L
    Neuroscience; 2010 Feb; 165(3):736-48. PubMed ID: 19883737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
    Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
    Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excitotoxic superoxide production and neuronal death require both ionotropic and non-ionotropic NMDA receptor signaling.
    Minnella AM; Zhao JX; Jiang X; Jakobsen E; Lu F; Wu L; El-Benna J; Gray JA; Swanson RA
    Sci Rep; 2018 Nov; 8(1):17522. PubMed ID: 30504838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ifenprodil, a NR2B-selective antagonist of NMDA receptor, inhibits reverse Na+/Ca2+ exchanger in neurons.
    Brittain MK; Brustovetsky T; Brittain JM; Khanna R; Cummins TR; Brustovetsky N
    Neuropharmacology; 2012 Nov; 63(6):974-82. PubMed ID: 22820271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
    Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia.
    Vieira MM; Schmidt J; Ferreira JS; She K; Oku S; Mele M; Santos AE; Duarte CB; Craig AM; Carvalho AL
    Neurobiol Dis; 2016 May; 89():223-34. PubMed ID: 26581639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.
    Goldsmith PJ
    Curr Top Med Chem; 2019; 19(24):2239-2253. PubMed ID: 31660834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GluN1/GluN2B NMDA receptor and metabotropic glutamate receptor 1 negative allosteric modulator has enhanced neuroprotection in a rat subarachnoid hemorrhage model.
    Zhang Z; Liu J; Fan C; Mao L; Xie R; Wang S; Yang M; Yuan H; Yang X; Sun J; Wang J; Kong J; Huang S; Sun B
    Exp Neurol; 2018 Mar; 301(Pt A):13-25. PubMed ID: 29258835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive allosteric modulation of NMDA receptors: mechanisms, physiological impact and therapeutic potential.
    Geoffroy C; Paoletti P; Mony L
    J Physiol; 2022 Jan; 600(2):233-259. PubMed ID: 34339523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Biological Evaluation of Novel Multi-target-Directed Benzazepines Against Excitotoxicity.
    Machhi J; Prajapati N; Tripathi A; Parikh ZS; Kanhed AM; Patel K; Pillai PP; Giridhar R; Yadav MR
    Mol Neurobiol; 2017 Nov; 54(9):6697-6722. PubMed ID: 27744571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic
    Valente P; Kiryushko D; Sacchetti S; Machado P; Cobley CM; Mangini V; Porter AE; Spatz JP; Fleck RA; Benfenati F; Fiammengo R
    ACS Nano; 2020 Jun; 14(6):6866-6877. PubMed ID: 32510204
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic conantokin peptides potently inhibit N-methyl-D-aspartate receptor-mediated currents of retinal ganglion cells.
    Huang L; Balsara RD; Castellino FJ
    J Neurosci Res; 2014 Dec; 92(12):1767-74. PubMed ID: 25043917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Integrated Approach for Screening and Identification of Positive Allosteric Modulators of N-Methyl-D-Aspartate Receptors.
    Jambrina E; Cerne R; Smith E; Scampavia L; Cuadrado M; Findlay J; Krambis MJ; Wakulchik M; Chase P; Brunavs M; Burris KD; Gallagher P; Spicer TP; Ursu D
    J Biomol Screen; 2016 Jun; 21(5):468-79. PubMed ID: 26838761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular mild acidosis decreases the Ca
    Plutino S; Sciaccaluga M; Fucile S
    Cell Calcium; 2019 Jun; 80():63-70. PubMed ID: 30978540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural changes of regulatory domain heterodimer of N-methyl-D-aspartate receptor subunits GluN1 and GluN2B through the binding of spermine and ifenprodil.
    Tomitori H; Suganami A; Saiki R; Mizuno S; Yoshizawa Y; Masuko T; Tamura Y; Nishimura K; Toida T; Williams K; Kashiwagi K; Igarashi K
    J Pharmacol Exp Ther; 2012 Oct; 343(1):82-90. PubMed ID: 22743575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models.
    Liu P; Wang C; Chen W; Kang Y; Liu W; Qiu Z; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
    Phytomedicine; 2023 Jan; 109():154594. PubMed ID: 36610115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.